Urgent: Hydroxycut Suits Have Recently Been Reported
On May one, 2009, there was a recall of fourteen Hydroxycut diet-aid products coming from a number of reports that people using the products were developing significant liver issues and other health worries. Less than a week later, on May 4, the 1st Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Settlements alleges company failure in informing the public about potential risks of the products. Naturally, it’s too shortly to understand the suit is going to turn out, but if the company had information which it didn’t divulge to customers, it should definitely be held accountable.
A class action legal action is filed by a bunch of folks, all of whom have similar claims against a certain company. Filing a class action is just as effective, and much less pricey, than filing an individual suit. As a rule, filing a class action legal action will not cost you anything unless there is a settlement. At that time, the lawyer who handled the suit will take his fees from the compensation that was awarded and then distribute the leftover funds to the litigants in the case. Since this is the case, you will be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the explanations that class action legal actions became so popular.
The initial class action legal action against Iovate was filed in Canada where the company is found and represents all Canadian citizens who sustained health problems due to Hydroxycut products. The FDA recall happened in the US where twenty-three cases of liver disorders and other health problems had been reported. Health Canada did not receive any reports of liver damage caused by the diet products, but they did receive 17 reports concerning people who sustained respiration, neurological, heart, and gut problems as a consequence of Canadians using the products.
The Hydroxycut Liver Lawsuits alleges the company sold the company sold the general public of the health hazards that they could exposing patrons to. The complaint states that the company failed to publish the information on the product labels saying that users could run the risk of liver and kidney damage as well as gastrointestinal, cardiovascular, respiratory, and neurological problems. The suit goes on to claim this was an obvious omission on the part of the company which deliberately misled consumers concerning the protection of the products.
